US Stock MarketDetailed Quotes

AVXL Anavex Life Sciences

Watchlist
  • 5.090
  • +0.030+0.59%
Close Mar 28 16:00 ET
  • 5.090
  • 0.0000.00%
Post 17:13 ET
417.95MMarket Cap-9425P/E (TTM)

About Anavex Life Sciences Company

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Company Profile

SymbolAVXL
Company NameAnavex Life Sciences
Listing Date10/28/2015
Founded2004
CEOMr. Christopher U. Missling,PhD
MarketNASDAQ
Employees40
Securities TypeOrdinary Shares
Fiscal Year Ends09-30
Address630 5th Avenue,20th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10111
Phone1-844-689-3939

Company Executives

  • Name
  • Position
  • Salary
  • Christopher U. Missling,PhD
  • Director, President, Chief Executive Officer and Secretary
  • 6.75M
  • Sandra Boenisch, C.G.A.,C.P.A.
  • Principal Financial Officer, Principal Accounting Officer and Treasurer
  • 452.50K
  • Dr. Jiong Ma, PhD
  • Chairman of the Board
  • 407.12K
  • Athanasios Skarpelos
  • Independent Director
  • 407.12K
  • Dr. Steffen Thomas, PhD
  • Independent Director
  • 407.12K
  • Peter Donhauser, D.O.
  • Independent Director
  • 407.12K
  • Dr. Claus van der Velden, PhD
  • Independent Director
  • 423.12K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg